Efficacy evaluation on switching to 50mg of minodronic acid hydrate in patients with osteoporosis
Not Applicable
Completed
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000012226
- Lead Sponsor
- Yokkaichi Social Insurance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have withdrawn their consent to participation in the study -Patients who discontinued their medication with minodronic acid hydrate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in bone mineral density
- Secondary Outcome Measures
Name Time Method -Changes in bone metabolic markers -Changes in pain symptoms -Changes in abdominal symptoms -Changes in patients will for medication